1281 results found | searching for "Facebook"

First Previous 2 3 4 5 6 7 8 9 10 11 Next Last 
  • jameshebrew
  • The DNA and gene cloning services market is anticipated to grow at a CAGR of over 15% In order to avail benefits, such as technical competence, reduced cost, and fast delivery of high-quality DNA and gene customized clones, several players have demonstrated a preference to leverage expertise of DNA and gene cloning service providers. London Roots Analysis has announced the addition of “DNA and Gene Cloning Market , 2022-2035” report to its list of offerings. DNA and gene cloning have diverse applications, including modern biotechnological, medicinal, and several diagnostic ones as DNA and gene cloning has proven to be beneficial for research and development in the biopharmaceutical and healthcare industries. Presently, a number of players having dedicated facilities, cutting-edge machinery, and production lines, are offering DNA and gene cloning services to the various stakeholders in this domain. In 1973, a group of scientists reported that individual genes can be cloned and isolated by cleaving DNA enzymatically into DNA fragments. Over time, gene and DNA cloning has proved to be an important tool for researchers in their studies focused on genetics. To request a sample copy / brochure of this report, please visit link https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market/request-sample.html Key Market Insights Around 80 companies claim to offer DNA and gene cloning services, globally Majority (59%) of the stakeholders are headquartered in North America, followed by those based in Europe (22%), and Asia-Pacific (19%). Further, this segment of the industry is dominated by the presence of small players (11-50 employees), representing 35% of the total service providers. Close to 32% players claim to act as one-stop-shops, offering services for gene synthesis, custom cloning, and sub-cloning Close to 80% of the DNA and gene cloning service providers offer custom cloning, followed by companies offering gene synthesis (68%), sub-cloning (50%), and other services, such as RNA cloning and vector cloning (31%). It is worth mentioning that most of the service providers (61%) offer restriction enzyme-based cloning. Over 1,350 patents related to DNA and gene cloning in biopharmaceutical industry have been filed / granted since 2017 Owing to the increase in research and development efforts by various industry and non-industry players engaged in this domain, close to 60% of patent applications have been filed post-2018. It is worth noting that 57% patents related to DNA and gene cloning have been filed by non-industry players. Close to 6,900 articles related to DNA and gene cloning, have been published in reputed scientific journals since 2018 More than 45% of the articles focused on DNA and gene cloning were published post-2019. Popular journals that have published multiple articles include Methods in Molecular Biology, International Journal of Biological Macromolecules, Developmental and Comparative Immunology, Protein Expression and Purification, and International Journal of Molecular Sciences. Over 35 global events related to DNA and gene cloning have been organized since 2017 Majority of the events related to DNA and gene cloning were organized in Asia-Pacific (64%). It is worth highlighting that the agendas of the events organized post-2020 include discussions on the potential, advancements and challenges associated with DNA and gene cloning techniques. For additional details, please visit https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • moshehogeg002
  • Moshe Hogeg Website: https://seaislenews.com/moshe-hogeg-discusses-ethereum-blockchain-merge-software-upgrade/ Address: Tel Aviv, Israel Moshe Hogeg is a tech entrepreneur, the owner of Beitar Jerusalem football team, and chairman of blockchain research at the University of Tel Aviv in Israel. #Horse Racing #Moshe Hogeg Facebook: https://www.facebook.com/hogeg/ Instagram: https://www.instagram.com/moshehogeg/
  • jameshebrew
  • The human microbiome market is anticipated to grow at a CAGR of 24% till 2035 With the increasing concept of precision medicine, several scientists have demonstrated interest in the therapeutic manipulation of human microbiome (commonly gut bacteria) for the treatment of a wide range of disease indications. Roots Analysis has announced the addition of “The Human Microbiome Market, (4th Edition) 2022-2035” report to its list of offerings. The microbiome-based therapies pipeline features six drugs in phase III clinical development, over 200 candidates in other clinical and preclinical stages of development along with more than 60 diagnostics and screening / profiling tests that are commercialized for the detection of various diseases. However, the current microbiome market is driven by the fecal microbiota therapies approved by the FDA, particularly for the recurrent CDI and the commercialized diagnostic tests available to the patients. The human microbiome remained a largely unexplored area until 2007 when the Human Microbiome Project (HMP) was initiated. Given the role of microbiota in disease development and pathogenesis, the concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, thereby, defining a new frontier in the field of medicine. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/281/request-sample.html Key Market Insights Over 230 drug candidates are currently being developed by more than 70 drug developers Nearly 30% of the pipeline drugs are in clinical phase of development, while more than 150 drugs are in preclinical and discovery stages. Clinical stage drugs are primarily being developed for infectious diseases and digestive disorders, while candidates in preclinical and discovery stages are focused on oncological disorders. More than 75 diagnostics and screening / profiling test are available / under development Of these, around 80% of the tests are available in the market, while rest are under development. More than 40 companies are engaged in providing these tests; these are primarily based in North America (45%) and Europe (39%). It is worth highlighting that majority (68%) of the players are small companies. FMTs are the only commercially available microbiome therapies approved by the FDA These therapies are primarily used for the treatment of recurrent Clostridium difficile infection (rCDIs). It is worth mentioning that more than 400 trials have been registered for evaluating these therapies for a wide range of indications. Partnership activity in this domain has increased at a CAGR of 26%, between 2017 and 2021 Maximum number of partnerships were established in 2021, indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that majority of the deals were R&D agreements, representing over 35% of the total number of partnerships signed in the given time period. More than USD 1 billion has been invested by both private and public investors, since 2017 Of the total amount invested, over USD 563 million was raised through venture capital financing, representing over 56% of the overall funding activity in this domain. Further, 36 instances of grants / awards were also reported, wherein players collectively raised more than USD 137 million. Outsourcing has become an integral part of the microbiome and live biotherapeutics development process Presently, over 25 service providers claim to offer a multitude of contract manufacturing services for microbiome and live biotherapeutic products. It is worth noting that close to 10 firms were established post 2010 and around 45% of the players are located in Europe. Microbiome therapeutics are anticipated to capture more than 60% share of total microbiome market by 2035 As late-stage therapeutics will get approved by the FDA in the foreseen future, the microbiome therapeutics market is likely to grow at an annualized rate of 37% till 2035. It is worth mentioning that microbiome diagnostics is likely to capture 20% of the total microbiome market share by 2035. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • jameshebrew
  • Oral Proteins and Peptides Market Over the years, advances in recombinant DNA technology and ex vivo synthesis of biomolecules have led to the development and (in some cases) approval of several protein / peptide-based therapeutics. Considering the therapeutic advantages associated with proteins and peptides, this field has witnessed significant activity; researchers are actively evaluating orally bioavailable interventions. However, owing to their inherently complex structure and comparatively low stability (in in vivo conditions), proteins / peptides are predominantly administered parenterally. Recent strides in drug delivery solutions have enabled scientists to successfully explore and exploit alternative routes of drug delivery, such as transdermal, intranasal, pulmonary and oral, for protein / peptide-based therapeutics. Of these, the oral route of delivery is considered to be the most patient-friendly. This has led several companies to invest in the development of orally administered biologics. The delivery of proteins and peptides utilizes the following routes of administration. Since the approval of the first protein / peptide-based therapy (recombinant human insulin) in 1982, there has been a substantial increase in the R&D initiatives focused on such products. Earlier, majority of the biologics were administered subcutaneously. However, with the technological advancements in delivery formulations, oral delivery of therapeutic interventions has gained significant traction, prompting stakeholders to leverage their expertise in the development of orally administrable proteins / peptides. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/192/request-sample.html Although studies have reported that over XX oral drug delivery technologies have been designed so far, our research indicates that only XX% of the aforementioned technologies are currently being used to develop therapeutic proteins / peptides. Owing to the numerous advantages of oral drug delivery, including ease of administration, minimal pain and risk of drug reaction, and self-administration, we are led to believe that the oral proteins / peptide therapeutics market is anticipated to witness significant growth in the coming future. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/oral-proteins-and-peptides-market/192.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • Cynoinfotech
  • MAGENTO 2 SITE MAINTENANCE The Countdown Extension provides user subscriber facilities by news later. The visitor can contact the administrator by providing an email using this form. The administrator will get an email and inform subscribers when a new upcoming is ready in a web store or website is launched. So it is helpful to connect directly to the web store user. Countdown Extension is social-networks-friendly, so the website doesn’t need any additional way to allow their customers to share their posts on Google+, Twitter, Facebook, Pinterest. https://www.cynoinfotech.com/product/site-maintenance-for-magento-2/ [more]
  • jameshebrew
  • The cell invasion and migration assays market is projected to grow at a CAGR of 8% In recent years, the potential of cell invasion and migration assays with respect to discovery, diagnosis and screening of diseases has been widely recognized, which has further presented lucrative opportunities for players offering such products. London Roots Analysis has announced the addition of the “Cell Invasion and Migration Assays Market, 2022–2035” report to its list of offerings. Owing to several advantages offered by cell invasion and migration assays in analyzing and quantifying cellular mechanisms, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such assays to expediate discovery timelines and optimize the total development cost. Considering the various advantages offered by these cell-based assays, researchers across the globe have undertaken several initiatives to use these platforms for the diagnosis of a myriad of disease indications. The advancements in various technologies have propelled life science companies to use these assays in the drug discovery process, to enable the identification of potential lead candidates. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market/request-sample.html Key Market Insights Presently, more than 80% of the total assay providers are based in North America This segment of the industry is dominated by the presence of companies that were established pre-2000 (64%), followed by firms established during 2000-2010 (27%). In addition, most of the players engaged in this domain are small firms (less than 100 employees), representing over 45% of the total assay providers. Currently, over 80 cell invasion and migration assays are available in the market It is worth noting that most of the cell invasion and migration assays are currently being used for tumor studies (89%), followed by those employed for screening purposes (79%). Further, most of the assays are being developed for adherent cell cultures (48%), followed by those being manufactured for both adherent and suspension cell cultures (40%). 55% players claim to be capable of offering both cell invasion as well as cell migration assays 64% of the cell invasion and migration assays can be stored under frozen temperature (-18°C to -40°C), followed by those stored under refrigerated conditions (+1°C to +18°C) (36%). Further, it is worth noting that most of the cell invasion and migration assays are being used to conduct 100 tests (37%). This was followed by assays being developed to conduct 12 (35%) and 96 tests (23%). Over 650 articles focused on cell invasion and migration assays have been published, since 2021 Majority of the scientific literature published in this domain was focused on research (96%), followed by review articles (4%). It is worth mentioning that articles related to cell invasion and migration assays have been affiliated by over 300 universities. Patents filed / granted for cell invasion and migration assays have increased at a CAGR of more than 45%, since 2017 Of the total, around 55% of the patents were applications, followed by those that have been granted approval (45%). Around 63% of these intellectual property documents were filed / granted in North America; with the maximum number of patents having been filed in the US, since 2017. For additional details, please visit https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market.html You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • Anvsupport
  • How do I speak to a live person at Facebook? Searching for How do I speak to a live person at Facebook? Check out the contact info on Facebook here for quick help. Source URL: https://www.questohub.com/blog/quick-ways-to-contact-live-person-at-facebook [more]
  • Jatingera
  • Chatbots are computer programs designed to respond to messages automatically. Chatbots can be configured to react consistently, differently to messages containing particular keywords, or even to employ machine learning to modify their responses based on the context. Chatbots use channels including SMS text, website chat windows, and social messaging services on platforms like WhatsApp, Facebook, and Telegram to receive and respond to messages. https://botpenguin.com/what-is-marketing-chatbot-how-it-can-help-in-improving-business/ [more]
  • Jatingera
  • One of the most important pillars is “Marketing”. And a new trend came: businesses or brands getting active on social media platforms to engage the potential audience base, let people know about their products and services, and a lot more. Earlier, marketing was done through e-books, videos, and infographics, but no more new techniques have been adopted worldwide. https://botpenguin.com/reasons-your-business-needs-a-facebook-messenger-bot/ [more]
  • jameshebrew
  • The RNA sequencing services market is anticipated to grow at a CAGR of ~8% by 2035 In order to avail benefits, such as technical competence in sequencing large-sized genes, reduced cost, and fast delivery of high-quality data, researchers and industry players have demonstrated a preference to outsource RNA sequencing. London Roots Analysis has announced the addition of “RNA Sequencing Services Market, 2022-2035” report to its list of offerings. Despite the various technological advancements in RNA sequencing, there are several existing challenges, including difficulty in the sequencing of large-sized genes, shortage of human resources, lack of tools for data manipulation and analysis, and high capital requirement. In order to overcome these challenges and obtain a high-quality output, the outsourcing of RNA sequencing is considered as a preferable option, among other alternatives, by the companies engaged in RNA sequencing. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/rna-sequencing-services-market/request-sample.html Key Market Insights Currently, more than 70 companies claim to offer RNA sequencing services, globally Nearly 70% of the RNA sequencing service providers have been established post 2000, most of these are located in North America (58%) followed by Europe (22%). Further this segment of the industry is dominated by presence of mid-sized players (51-1,000 employees), representing 44% of the total service providers. Nearly 75% of the companies employ Illumina’s sequencing platform Of these, nearly 20% players offer services related to small RNA sequencing, followed by those offering services for mRNA sequencing (19%). Further, more than 80% of players claim to offer turnaround time of less than two weeks for different types of RNA sequencing services. Close to 1,050 grants have been awarded to support the research initiatives focused on RNA sequencing, since 2018 Grants worth USD 487 million have been awarded to various companies / organizations working in this domain. Close to 85% of the grants have been awarded for less than five years, out of which 15% grants were funded by the National Cancer Institute. Over 340 patents related to RNA sequencing have been filed / granted, since 2018 Owing to the increase in research and development efforts by various industry and non-industry players engaged in this domain, close to 87% of patent applications have been filed post-2018. It is worth noting that 58% patents related to RNA sequencing were filed / granted in Asia Pacific, alone. Presently, more than 85 NGS library preparation kits are available in market for RNA sequencing Majority (75%) of the kits offer turnaround time of less than five hours, out of which 80% kits contain enzyme mix as components. Further, most of the kits (40%) use plasma as the starting material, followed by kits that use serum (34%) and saliva (8%) as input samples. North America and Europe are anticipated to capture larger share (~70%) of the market by 2035 The market will be primarily driven by RNA sequencing for research purposes (93%). Further, clinics and hospitals are expected to occupy larger share (45%) of the overall market (in terms of service-based revenues), by 2035. For additional details, please visit https://www.rootsanalysis.com/reports/rna-sequencing-services-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
First Previous 2 3 4 5 6 7 8 9 10 11 Next Last